Bacterial ribosome and essential enzymes

Bacterial ribosomal proteins and other enzymes represent a broad category of essential prokaryotic targets used in antimicrobial therapy. The bacterial ribosome, consisting of the 30S and 50S subunits, is responsible for translating genetic information into proteins and is targeted by classes like aminoglycosides and macrolides [1]. The 'other enzymes' component includes critical proteins such as DNA gyrase and topoisomerase IV, which are essential for DNA replication and targeted by fluoroquinolones [2]. Additionally, this category encompasses enzymes involved in cell wall synthesis, such as penicillin-binding proteins, and metabolic pathways like folate production [3]. These targets are clinically significant because their structural divergence from eukaryotic counterparts allows for selective toxicity against bacterial pathogens [4]. However, the broad nature of this classification reflects a group of distinct molecular entities rather than a single target, making it a non-specific designation in drug discovery [5]. The clinical utility of drugs hitting these targets is increasingly threatened by the global rise of antibiotic resistance mechanisms, such as target site modification or enzymatic inactivation [6].

Other names

Bacterial protein synthesis machineryProkaryotic ribosomal proteinsBacterial metabolic enzymes

Inhibition of protein synthesis by binding to ribosomal subunits (30S or 50S), inhibition of DNA replication via DNA gyrase/topoisomerase IV, and disruption of metabolic pathways such as folic acid synthesis or cell wall assembly.